Switzerland · 
Who invested in Engimmune Therapeutics?
Engimmune Therapeutics's investors include Novo Holdings.
Switzerland · Seed startup
Who invested in Engimmune Therapeutics
Funding summaryUpdated 26 Oct 2026
$16Mraised across 1 round since 2022, from 1 source
- Latest round
- Seed, $16MMay 2022
- Investors
- 1
The rounds
- May 2022
Founders and team
From Engimmune Therapeutics's own website: 1 on the team.
- Sarah Wehrle-WolfSenior Scientist Protein Engineering
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Engimmune Therapeutics
How much has Engimmune Therapeutics raised?
Engimmune Therapeutics has raised $16M across 1 round since 2022.
When did Engimmune Therapeutics last raise?
Engimmune Therapeutics's most recent round was a Seed of $16M in May 2022.
What was Engimmune Therapeutics's biggest round?
Its most recent round, $16M in May 2022, is also its largest on record.
Who backed Engimmune Therapeutics first?
Engimmune Therapeutics's first round on record, in May 2022, was backed by Novo Holdings.
What stage is Engimmune Therapeutics at?
Engimmune Therapeutics's latest named round is a Seed, in May 2022.
Where is Engimmune Therapeutics based?
Engimmune Therapeutics is based in Switzerland.
Companies like Engimmune Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.